From February 19, 2024 to March 31, 2024, the company has repurchased 3,860,109 shares, representing 0.85% for CNY 32.31 million. With this, the company has completed the repurchase of 3,860,109 shares, representing 0.85% for CNY 32.31 million under the buyback announced on February 21, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 CNY | -0.60% |
|
-5.84% | -25.14% |
06-26 | Sinotherapeutics Secures Regulatory Nod for Two Drugs | MT |
04-29 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-25.14% | 508M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- 688247 Stock
- News Sinotherapeutics Inc.
- Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.